AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stein, E. A.
Right arrow Articles by Gartside, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stein, E. A.
Right arrow Articles by Gartside, P.
Agricola
Right arrow Articles by Stein, E. A.
Right arrow Articles by Gartside, P.

American Journal of Clinical Nutrition, Vol 35, 1375-1390, Copyright © 1982 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated, and total fat in free- living normal and hypercholesterolemic children

EA Stein, J Shapero, C McNerney, CJ Glueck, T Tracy and P Gartside

To assess the effects of dietary cholesterol and the amount and type of fat on plasma lipid and lipoproteins, nutrient intakes were altered sequentially over 15 months in 11 normal children and 12 children with heterozygous familial hypercholesterolemia. After a 3-month base-line assessment period, on an ad libitum diet, the following diets were given sequentially for three months each: dietary cholesterol greater than 450 mg/day, total fat less than 35% of total calories, and polyunsaturated fat to saturated fat ratio (P/S) greater than 1.5 (diet 1); dietary cholesterol less than 160 mg/day, total fat less than 35% total calories and P/S greater than 1.5 (diet 2); dietary cholesterol less than 160 mg/day, total fat 40% total calories P/S = 1 (diet 3), and dietary cholesterol greater than 450 mg/day total fat greater than 40% total calories, P/S less than 0.04 (diet 4). In normal and familial hypercholesterolemic children the high dietary P/S ratio lowered total and low-density lipoprotein cholesterol in the presence of high dietary cholesterol; sharp reductions in dietary cholesterol lowered the total and low-density lipoprotein cholesterol slightly in familial hypercholesterolemia subjects when P/S was high. High-density lipoprotein cholesterol was not affected by large changes in dietary cholesterol or amount or type of fat. Sustained dietary alteration which significantly lowers total and low-density lipoprotein cholesterol with commercially available products is achievable and practical in free-living children.


This article has been cited by other articles:


Home page
CLIN PEDIATRHome page
M. Sanchez-Bayle, A. Gonzalez-Requejo, J. Asensio-Anton, C. Ruiz-Jarabo, M. L. Fernandez-Ruiz, and J. Baeza
The Effect of Fiber Supplementation on Lipid Profile in Children with Hypercholesterolemia
Clinical Pediatrics, May 1, 2001; 40(5): 291 - 294.
[PDF]


Home page
Am. J. Clin. Nutr.Home page
R. M Lauer, E. Obarzanek, S. A Hunsberger, L. Van Horn, V. W Hartmuller, B. A Barton, V. J Stevens, P. O Kwiterovich Jr, F. A Franklin Jr, S. Y. Kimm, et al.
Efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol in children with elevated LDL cholesterol: the Dietary Intervention Study in Children
Am. J. Clinical Nutrition, November 1, 2000; 72 (5): 1332S - 1342S.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Rask-Nissila, E. Jokinen, T. Ronnemaa, J. Viikari, A. Tammi, H. Niinikoski, R. Seppanen, J. Tuominen, and O. Simell
Prospective, Randomized, Infancy-Onset Trial of the Effects of a Low-Saturated-Fat, Low-Cholesterol Diet on Serum Lipids and Lipoproteins Before School Age : The Special Turku Coronary Risk Factor Intervention Project (STRIP)
Circulation, September 26, 2000; 102(13): 1477 - 1483.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. A. Stein, D. R. Illingworth, P. O. Kwiterovich Jr, C. A. Liacouras, M. A. Siimes, M. S. Jacobson, T. G. Brewster, P. Hopkins, M. Davidson, K. Graham, et al.
Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia: A Randomized Controlled Trial
JAMA, January 13, 1999; 281(2): 137 - 144.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by The American Society for Nutrition